Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Acquisition

18 May 2022 07:00

RNS Number : 9061L
Sopheon PLC
18 May 2022
 

SOPHEON PLC

("Sopheon" or the "Company")

 

Acquisition of Solverboard accelerates Sopheon growth strategy

Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, is pleased to announce the acquisition of the business and assets of Solverlink Limited (trading as Solverboard® "Solverboard"), a UK based cloud-based business specializing in the front-end of innovation management.

Solverboard's multi-tenant, SaaS product is used by both individual innovators and product professionals, and is sold using an online, product-led growth ("PLG") model. Solverboard brings the innovation and product needs of professionals together so that they can focus on addressing front-end innovation challenges, increasing time to value by helping companies dynamically find, align, test and deliver the best innovation and product ideas from employees and customers.

Rationale for acquisition

In our last annual report we noted that Sopheon will be introducing new cloud-based applications this year, providing value to individual and workgroup users in the corporate ecosystem, alongside and integrated with the group's Accolade® enterprise software. These new applications are intended to drive lead generation for Accolade, as well as being stand-alone solutions that solve individual and workgroup productivity needs. The acquisition of Solverboard brings PLG capabilities into Sopheon more rapidly than previously planned, and accelerates this SaaS strategy from both functional and go-to-market perspectives.  Sopheon will continue to offer a free version of Solverboard and a paid subscription with more advanced features. We expect to introduce additional Sopheon products to be sold through the Solverboard channel by the end of the year.

Deal structure and consideration

The transaction is structured as a business and asset purchase. Initial consideration comprises £500,000 in cash and £250,000 in shares issued at £6 per share. An additional, contingent deferred earn-out of up to £1.55 million is payable over the next two years, linked to Annual Recurring Revenue ("ARR") targets. The earn-out consideration will be satisfied by up to £900,000 in shares issued at £6 per share, with the balance in cash. The cash consideration component of the acquisition is being funded out of existing and healthy cash resources. The share consideration elements are subject to lock in and orderly market restrictions.

 

Since inception, over £3 million has been invested in the Solverboard business and products by Solverboard's founders and management. A new platform was launched in September 2021, and has secured a number of customers to its free tier but is yet to generate material revenues. The costs of the business will be absorbed into Sopheon's current operating plans, through the reprioritization of planned spend.

Greg Coticchia, CEO of Sopheon said: "This acquisition is another step in our mission to provide the most comprehensive innovation system for the world's best companies. As well as its functional capabilities in the front end of innovation, adding Solverboard's expertise immediately brings us deep PLG go-to-market capabilities that were on our development roadmap. This is the second acquisition of a cloud-native, multi-tenant SaaS solution by Sopheon in the past six months. We look to the Solverboard and ROI Blueprints acquisitions to accelerate Sopheon's shift to a pure play SaaS model and associated ARR growth."

Solverboard founder and CEO Phil Atherton added: "It is very exciting to become part of Sopheon, a leader in the Enterprise Innovation Management space. Our companies are a perfect fit in vision, purpose and culture. Solverboard's product-led "go to market" capability for innovation and product professionals is highly complementary to Sopheon's market-leading sales-led enterprise go-to-market capability. We believe this combination will be pretty unique in our sector."

 

 

Allotment and issue of shares

Sopheon has allotted 41,667 new Ordinary Shares of 20 pence each in the Company to satisfy the share component of the initial consideration. Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 23 May 2022. The new Ordinary Shares will rank pari-passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,594,992. The Company does not hold any shares in treasury. Accordingly, the figure of 10,594,992 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information contact:

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)

Alice Lane / Sunila de Silva (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

Sopheon, Accolade and Solverboard are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBKFBDPBKKPPD
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.